| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp (EXAS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. EXAS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 191.9K | - | - | |
| VP | 153.7K | - | - | |
| CFO | 138.7K | - | - | |
| VP | 137.2K | - | - | |
| Dir | 13.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2019 | Wyzga Michael S | Director | Sale+OE | 5,000 | $117.93 | $589,650.00 | -35.9% | |
| Jul 31, 2019 | Levangie Daniel J | Director | Sale+OE | 42,607 | $117.64 | $5,012,397.77 | -16.6% | |
| Jul 30, 2019 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sale+OE | 9,845 | $105.60 | $1,039,632.00 | -16.5% | |
| Apr 3, 2019 | Stenhouse Mark | President, Cologuard | Sale+OE | 11,192 | $92.54 | $1,035,696.49 | -43.9% | |
| Mar 11, 2019 | Coward D Scott77 | Chief Administrative Officer | Sale+OE | 2,774 | $87.21 | $241,926.09 | -2.6% | |
| Mar 11, 2019 | Conroy Kevin T81 | President And CEO | Sale+OE | 11,227 | $87.21 | $979,129.12 | -1.2% | |
| Feb 28, 2019 | Zanotti Katherine S50 | Director | Sell | 25,000 | $92.81 | $2,320,230.85 | -4.8% | |
| Feb 28, 2019 | Johnson Scott C. | SVP - Research And Development | Sell | 1,166 | $93.20 | $108,675.86 | -13.2% | |
| Feb 28, 2019 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 2,447 | $93.20 | $228,070.19 | -5.7% | |
| Feb 28, 2019 | Coward D Scott77 | Chief Administrative Officer | Sell | 2,447 | $93.20 | $228,070.19 | -2.4% |